PEN vs NBIX
Penumbra, Inc. vs Neurocrine Biosciences — AI-powered side-by-side comparison
| Metric | PEN | NBIX |
|---|---|---|
| AI Score | 59 | 66 |
| Price | $321.11 | $166.76 |
| P/E Ratio | 78.53× | 23.66× |
| ROE | 0.1% | 0.1% |
| Revenue Growth YoY | — | — |
| Gross Margin | 0.7% | 1.0% |
| Debt / Equity | 0.14× | 0.10× |
| Dividend Yield | 0.0% | 0.0% |
| RSI (14) | 70.3 | 36.6 |
| Beta | 0.699 | 0.3859 |
| Expected Upside | +8.0% | — |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
PEN Full Analysis
NBIX Full Analysis